Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Brain : a Journal of Neurology
|
July 5, 2012
The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke
Nikos Gorgoraptis, Yee-Haur Mah, Bjoern Machner, et al.
Computer Methods and Programs in Biomedicine
|
February 14, 2025
Neuradicon: Operational representation learning of neuroimaging reports
Henry Watkins, Robert Gray, Adam Julius, et al.
Epilepsia Open
|
March 21, 2023
Antiepileptogenesis after stroke-trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate
Matthias J Koepp, Eugen Trinka, Yee-Haur Mah, et al.
European Stroke Journal
|
April 5, 2021
Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol
Joanna M Wardlaw, Fergus Doubal, Rosalind Brown, et al.
The Lancet. Neurology
|
February 21, 2026
Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial
Matthias J Koepp, Eugen Trinka, Yee-Haur Mah, et al.
Cerebrovascular Diseases Extra
|
June 29, 2026
Rates, risks and routes to reduce vascular dementia (R4VaD), a UK-wide multicentre prospective observational cohort study of cognition after stroke: baseline data and statistical analysis plan (ISRCTN18274006)
Philip M Bath, Ellen V Backhouse, Rosalind Brown, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Brain : a Journal of Neurology
|
July 5, 2012
The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke
Nikos Gorgoraptis, Yee-Haur Mah, Bjoern Machner, et al.
Computer Methods and Programs in Biomedicine
|
February 14, 2025
Neuradicon: Operational representation learning of neuroimaging reports
Henry Watkins, Robert Gray, Adam Julius, et al.
Epilepsia Open
|
March 21, 2023
Antiepileptogenesis after stroke-trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate
Matthias J Koepp, Eugen Trinka, Yee-Haur Mah, et al.
European Stroke Journal
|
April 5, 2021
Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol
Joanna M Wardlaw, Fergus Doubal, Rosalind Brown, et al.
The Lancet. Neurology
|
February 21, 2026
Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial
Matthias J Koepp, Eugen Trinka, Yee-Haur Mah, et al.
Cerebrovascular Diseases Extra
|
June 29, 2026
Rates, risks and routes to reduce vascular dementia (R4VaD), a UK-wide multicentre prospective observational cohort study of cognition after stroke: baseline data and statistical analysis plan (ISRCTN18274006)
Philip M Bath, Ellen V Backhouse, Rosalind Brown, et al.
Page
of 2